Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.080
+0.240 (13.04%)
Feb 20, 2026, 1:56 PM EST - Market open
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $4.66 million as of February 20, 2026. Its market cap has decreased by -63.99% in one year.
Market Cap
4.66M
Enterprise Value
-1.69M
1-Year Change
-63.99%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $4.66M, a decrease of -90.27%. That is a compound annual growth rate of -40.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 4.13M | -19.04% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 4.94M |
| Processa Pharmaceuticals | 4.94M |
| Decoy Therapeutics | 4.79M |
| Cyclerion Therapeutics | 4.72M |
| Aprea Therapeutics | 4.20M |
| Genprex | 4.17M |
| 60 Degrees Pharmaceuticals | 4.13M |
| Silo Pharma | 4.03M |